Jitendra Wadhane serves as Executive at Pyxis Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Jitendra Wadhane has executed 8 insider transactions totaling $17.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 26, 2024 involved receiving (via award) 131,484 shares valued at $0.
Jitendra Wadhane currently holds 398,421 shares of Pyxis Oncology, Inc. (PYXS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jitendra Wadhane has been a net buyer of PYXS stock. They have purchased $17.9K and sold $0 worth of shares.
Jitendra Wadhane's most recent insider trade was on Mar 26, 2024, when they sold 131,484 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 27, 2023 | PYXS | $4.7K | Purchase | 2,500 | $1.87 | Discretionary |
| Sep 25, 2023 | PYXS | $8.8K | Purchase | 5,000 | $1.77 | Discretionary |
| Sep 22, 2023 | PYXS | $4.3K | Purchase | 2,500 | $1.74 | Discretionary |
| Sep 7, 2023 | PYXS | $0 | Award | 93,896 | $N/A | Discretionary |
| Mar 24, 2023 | PYXS | $0 | Award | 45,000 | $N/A | Discretionary |
| Mar 24, 2023 | PYXS | $0 | Award | 29,393 | $N/A | Discretionary |